143 related articles for article (PubMed ID: 31663415)
1. Optimisation of methadone treatment in a group of patients on a mephedrone binge and dependent on many psychoactive substances.
Ordak M; Nasierowski T; Muszynska E; Bujalska-Zadrozny M
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):38-42. PubMed ID: 31663415
[No Abstract] [Full Text] [Related]
2. Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010-19.
Ordak M; Nasierowski T; Pawlik K; Muszynska E; Bujalska-Zadrozny M
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):322-327. PubMed ID: 32491921
[No Abstract] [Full Text] [Related]
3. The Psychiatric Characteristics of People on a Mephedrone ("bath salts") Binge.
Ordak M; Nasierowski T; Muszynska E; Bujalska-Zadrozny M
Subst Use Misuse; 2020; 55(10):1610-1617. PubMed ID: 32306799
[No Abstract] [Full Text] [Related]
4. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'.
Freeman TP; Morgan CJ; Vaughn-Jones J; Hussain N; Karimi K; Curran HV
Addiction; 2012 Apr; 107(4):792-800. PubMed ID: 22257011
[TBL] [Abstract][Full Text] [Related]
5. Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises.
Kintz P
Curr Neuropharmacol; 2017; 15(5):658-662. PubMed ID: 27784226
[TBL] [Abstract][Full Text] [Related]
6. The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.
Karila L; Billieux J; Benyamina A; Lançon C; Cottencin O
Brain Res Bull; 2016 Sep; 126(Pt 1):61-67. PubMed ID: 26995278
[TBL] [Abstract][Full Text] [Related]
7. Mephedrone (4-methylmethcathinone)-related deaths.
Maskell PD; De Paoli G; Seneviratne C; Pounder DJ
J Anal Toxicol; 2011 Apr; 35(3):188-91. PubMed ID: 21439157
[TBL] [Abstract][Full Text] [Related]
8. Mephedrone use among same-sex attracted young people in Sydney, Australia.
Lea T; Reynolds R; De Wit J
Drug Alcohol Rev; 2011 Jul; 30(4):438-40. PubMed ID: 21450044
[TBL] [Abstract][Full Text] [Related]
9. [Mephedrone: a designer drug of recent use in France].
Debruyne D; Courné MA; Le Boisselier R; Djezzar S; Gérardin M; Boucher A; Karila L; Coquerel A; Mallaret M
Therapie; 2010; 65(6):519-24. PubMed ID: 21176758
[TBL] [Abstract][Full Text] [Related]
10. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.
Schifano F; Albanese A; Fergus S; Stair JL; Deluca P; Corazza O; Davey Z; Corkery J; Siemann H; Scherbaum N; Farre' M; Torrens M; Demetrovics Z; Ghodse AH; ;
Psychopharmacology (Berl); 2011 Apr; 214(3):593-602. PubMed ID: 21072502
[TBL] [Abstract][Full Text] [Related]
11. Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.
McElrath K; O'Neill C
Int J Drug Policy; 2011 Mar; 22(2):120-7. PubMed ID: 21242082
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Ahmadi J; Razeghian Jahromi L
Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
[TBL] [Abstract][Full Text] [Related]
13. Novel psychoactive substances: An investigation of temporal trends in social media and electronic health records.
Kolliakou A; Ball M; Derczynski L; Chandran D; Gkotsis G; Deluca P; Jackson R; Shetty H; Stewart R
Eur Psychiatry; 2016 Oct; 38():15-21. PubMed ID: 27611330
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern.
Alammehrjerdi Z; Ezard N; Dolan K
Asian J Psychiatr; 2018 Jan; 31():49-55. PubMed ID: 29414387
[TBL] [Abstract][Full Text] [Related]
15. [Mephedrone].
Bertrand X; Gensburger M; Steckx E
Rev Med Liege; 2011 Oct; 66(10):540-4. PubMed ID: 22141261
[TBL] [Abstract][Full Text] [Related]
16. Deaths of individuals aged 16-24 years in the UK after using mephedrone.
Loi B; Corkery JM; Claridge H; Goodair C; Chiappini S; Gimeno Clemente C; Schifano F
Hum Psychopharmacol; 2015 Jul; 30(4):225-32. PubMed ID: 26216555
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity Induced by Mephedrone: An up-to-date Review.
Pantano F; Tittarelli R; Mannocchi G; Pacifici R; di Luca A; Busardò FP; Marinelli E
Curr Neuropharmacol; 2017; 15(5):738-749. PubMed ID: 27908258
[TBL] [Abstract][Full Text] [Related]
18. Mephedrone related fatalities: a review.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3777-90. PubMed ID: 26502870
[TBL] [Abstract][Full Text] [Related]
19. UK places generic ban on mephedrone drug family.
Morris K
Lancet; 2010 Apr; 375(9723):1333-4. PubMed ID: 20405534
[No Abstract] [Full Text] [Related]
20. Mephedrone (4-methylmethcathinone): what is new in our understanding of its use and toxicity.
Wood DM; Dargan PI
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):227-33. PubMed ID: 22564711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
